United States · FDA National Drug Code directory
Kisunla
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0002-9401_85d3d68b-57f9-45e6-a1a7-fa19bc843f33
- Product NDC
- 0002-9401
- Form
- INJECTION, SOLUTION
- Composition / generic term
- donanemab-azbt
- Labeler
- Eli Lilly and Company
- Marketing category
- BLA
- Marketing start / end (source format)
- 20240702
- Source listing expiry
- 20261231
Source-listed ingredients
- DONANEMAB — 17.5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (0002-9401-01) / 20 mL in 1 VIAL, SINGLE-DOSE · 0002-9401-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →